Animal and Human Dose-Response Models for Brucella Species

Risk Analysis

Volumn 31, Issue 10, 2011, Pages 1576-1596

  Teske, Sondra S ^a   Huang, Yin ^b   Tamrakar, Sushil B ^a   Bartrand, Timothy A ^c   Weir, Mark H ^b   Haas, Charles N ^a  

^a Drexel University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c TETRA TECH INC   (United States)

Author keywords

Brucellosis, dose response model; Microbial risk assessment

Indexed keywords

BRUCELLA; CENTER FOR DISEASE CONTROLS; COLONY FORMING UNITS; DISEASE TRANSMISSION; DOSE RESPONSE; DOSE RESPONSE RELATIONSHIPS; DOSE-RESPONSE MODELS; GUINEA PIGS; HUMAN HEALTH; LITERATURE SEARCH; MICROBIAL RISK ASSESSMENT; PARALLEL MODELS; PROGRAMMING LANGUAGE; QUANTITATIVE RISK ASSESSMENT; SUBCUTANEOUS ROUTE; ZOONOTIC DISEASE;

AGRICULTURE; DISEASE CONTROL; DISEASES; MAMMALS; MAXIMUM LIKELIHOOD ESTIMATION; RISK ASSESSMENT; RISK PERCEPTION;

HEALTH RISKS;

AEROSOL; BACTERIAL DISEASE; BIOTERRORISM; DISEASE TRANSMISSION; DOSE-RESPONSE RELATIONSHIP; INFECTIVITY; INGESTION RATE; INOCULATION; LITERATURE REVIEW; LIVESTOCK; MAXIMUM LIKELIHOOD ANALYSIS; NUMERICAL MODEL; PRIMATE; PUBLIC HEALTH; RISK ASSESSMENT; RODENT; VACCINE;

ANIMAL; ARTICLE; BRUCELLA; GUINEA PIG; HUMAN; PHYSIOLOGY; POISSON DISTRIBUTION; STATISTICAL MODEL; THEORETICAL MODEL;

ANIMALS; BRUCELLA; GUINEA PIGS; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, THEORETICAL; POISSON DISTRIBUTION;

ANIMALIA; BRUCELLA; CAVIA; MACACA MULATTA; MUS;

EID: 80054096757     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01602.x     Document Type: Article

References (50)

1. Corbel MJ. Brucellosis: An overview. Emerging Infectious Diseases, 1997; 3:2123-2221.
2. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infectious Diseases, 2007; 7:775-786.
3. Mantur BG, Mallangouda SB, Bidri RC, Mulimani MS, Veerappa K, Kariholu P, Patil SB, Mangalgi SS. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. Journal of Medical Microbiology, 2006; 55:897-903.
4. Mantur BG, Amarnath SK. Brucellosis in India-A review. Journal of Bioscience, 2008; 33(4):539-547.
5. Young E. Human brucellosis. Review of Infectious Diseases, 1983; 5:821-842.
6. Young E. An overview of human brucellosis. Clinical Infectious Diseases, 1995; 21:283-289.
7. Corbel MJ. Brucella. Pp. 339-353 in Parker MT, Collier LH (eds). Topley and Wilson's Principles of Bacteriology, Virology and Immunology, 8th edition. London, UK Edward Arnold, 1990.
8. Jahans KL, Foster G, Broughton ES. The characterisation of Brucella strains isolated from marine mammals. Veterinary Microbiology, 1997; 57:373-382.
9. Mantur BG, Amarnath SK. Brucellosis in India-A review. Journal of Bioscience, 2008; 33(4): 539-547.
10. Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infection, Genetics and Evolution, 2009; 9:1168-1184.
11. Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection? Critical Reviews in Immunology, 2006; 26:407-422.
12. Pappas G, Papdimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infectious Diseases, 2006; 6:91-99.
13. Lundervold M, Milner-Gulland EJ, O'Callahan CJ, Hamblin C, Corteyn A, Macmillan AP. A serological survey of ruminant livestock in Kazakhstan during post-Soviet transitions in farming and disease control. Acta Veterinaria Scandinavica, 2004; 45:211-244.
14. Manaseki S. Mongolia: A health system in transition. British Medical Journal, 1993; 307:1609-1611.
15. Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, Carrin G, Otte J. Human health benefits from livestock vaccination for brucellosis: Case study. Bulletin of the World Health Organization, 2003; 81:867-876.
16. Trout D, Gomez TM, Bernard BP, Mueller CA, Smith CG, Hunter L, Kiefer M. Outbreak of brucellosis at a United States pork packing plant. Journal of Occupational and Environmental Medicine, 1995; 37(6):697-703.
17. Chomel BB, DeBess EE, Mangiamele DM, Reilly KF, Farver TB, Sun RK, Barrett LR. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: A shift toward foodborne transmission. Journal of Infectious Diseases, 1994; 170(5):1216-1223.
18. Ramos JM, Bernal E, Esguevillas T, Lopez-Garcia P, Gaztamibide MS, Gutierrez F. Non-imported brucellosis outbreak from unpasteurized raw milk in Moroccan immigrants in Spain. Epidemiology and Infection, 2008; 136:1552-1555.
19. Munoz PM, Boadella M, Arnal M, de Miguel MJ, Revilla M, Martinez D, Vicente J, Acevedo P, Oleaga A, Ruiz-Fons F, Marin CM, Prieto JM, de la Fuente J, Barral M, Barberan M, Fernandez de Luco D, Blasco JM, Gortazar C. Spatial distribution and risk factors of brucellosis in Iberian wild ungulates. BMC Infectious Diseases, 2010; 10(1):46-60.
20. Centers for Disease Control and Prevention (CDC). Bioterrorism Disease/Agents List. Available at:, Accessed on February 4, 2011.
21. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerging Infectious Diseases, 2005; 11(8):1180-1185.
22. Druett HA, Henderson DW, Peacock S. Studies on respiratory infection. III. Experiments with Brucella suis. Journal of Hygiene, 1956; 54(1):49-57.
23. Kleinman LI, Radford Jr, EP. Ventilation standards for small mammals. Journal of Applied Physiology, 1964; 19:360-362.
24. Henderson DW. An apparatus for the study of airborne infection. Journal of Hygiene, 1952; 50(1):53-68.
25. Elberg SS, Henderson DW. Respiratory pathogenicity of Brucella. Journal of Infectious Diseases, 1948; 82(3):302-306.
26. Druett HA, Henderson DW, Packman L, Peacock S. Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. Journal of Hygiene, 1953; 51(3):359-371.
27. Herzberg M, Elberg SS, Meyer KF. Immunization against Brucella infection II. Effectiveness of a streptomycin-dependent strain of Brucella melitensis. Journal of Bacteriology, 1953; 66(5):600-605.
28. Herzberg M, Elberg SS. Immunization against Brucella infection I. Isolation and characterization of a streptomycin-dependent mutant. Journal of Bacteriology, 1953; 66(5):585-599.
29. Elberg SS, Henderson DW, Herzberg M, Peacock S. Immunization against Brucella infection IV. Response of monkeys to injection of a streptomycin-dependent strain of Brucella melitensis. Journal of Bacteriology, 1955; 69(6):643-648.
30. Foster JW, Ribi E. Immunological role of Brucella abortus cell walls. Journal of Bacteriology, 1962; 84(2):258-268.
31. Pappagianis D, Elberg SS, Crouch D. Immunization against Brucella infections. Effects of graded doses of viable attenuated Brucella melitensis in humans. American Journal of Epidemiology, 1966; 84(1):21-31.
32. Haas CN, Rose JB, Gerba CP. Quantitative Microbial Risk Assessment. New York John Wiley, 1999.
33. Abramowitz M, Stegun IA. Pocketbook of mathematical functions. Verlag Harri Deutsch Thun Frankfurt/Main, 1984.
34. Teunis PFM, Havellar AH. The beta Poisson dose-response model is not a single hit model. Risk Analysis, 2000; 20(4):513-520.
35. Bartrand TA, Weir MA, Haas CN. Dose-response models for inhalation of Bacillus anthracis spores: Interspecies comparisons. Risk Analysis, 2008; 28(4):1115-1124.
36. Huang Y, Bartrand TA, Haas CN, Weir MH. Incorporating time post inoculation into a dose-response model of Yersinia pestis in mice. Journal of Applied Microbiology, 2009; 107:727-735.
37. Huang Y, Haas CN. Time-dose-response models for microbial risk assessment. Risk Analysis, 2009; 29(5):648-661.
38. Tamrakar SB, Haas CN. Dose-response model for Burkholderia pseudomallei (meliodosis). Journal of Applied Microbiology, 2008; 105:1361-1371.
39. DeVore JL (ed). Probability and Statistics for Engineering and the Sciences, 6th edition. Belmont, CA Brooks/Cole-Thomson Learning, 2004, pp. 168-170.
40. Foster G, Osterman BS, Godfroid J, Jacques I, Coeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. International Journal of Systematic and Evolutionary Microbiology, 2007; 57:2688-2693.
41. Roy CJ, Hale M, Hartings JM, Pitt L. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhalation Toxicology, 2003; 15:619-638.
42. Snipes MB. Kinetics of inhaled radionuclides. In Raabe OG (ed). Internal Radiation Dosimetry, Health Physics Society Summer School 1994. Madison, WI: Medical Physics Publishing, 1994.
43. Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. Brucella abortus infection acquired in microbiology laboratories. Journal of Clinical Microbiology, 2000; 38(5): 2005-2006.
44. Mense MG, Borshcel RH, Wilhelmsen CL, Pitt ML, Hoover DL. Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta). American Journal of Veterinary Research, 2004; 65(5):644-652.
45. Mantur BG, Mulimani MS, Bidari LH, Akki AS, Takare NV. Bacteremia is as unpredictable as clinical manifestations in human brucellosis. International Journal of Infectious Diseases, 2008; 12:303-307.
46. Izadjoo MJ, Mense MG, Bhattacharjee AK, Hadfield TL, Crawford RM. A study on the use of male animal models for developing a live vaccine for Brucellosis. Transboundary and Emerging Diseases, 2008; 55:145-151.
47. Olsen SC, Waters WR, Stoffregen WS. An aerosolized Brucella spp. challenge model for laboratory animals. Zoonoses Public Health, 2007; 54:281-285.
48. Chain PS, Comerci DJ, Tolmasky ME, Larimer FW, Malfatti SA, Vergez LM, Aguero F, Land ML, Ugalde RA, Garcia E. Whole-genome analyses of speciation events in pathogenic Brucellae. Infection and Immunity, 2005; 73: 8353-8361.
49. DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, Ivanova N, Anderson I, Bhattacharyya A, Lykdis A, Reznik G, Jablonski L, Larsen N, D'Souza M, Bernal A, Mazur M, Goltsman E, Selkov E, Elzer PH, Hagius S, O-Callaghan D, Letesson JJ, Haselkorn R, Krypides N, Overbeek R. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proceedings of the National Academy of Sciences USA, 2002; 99:443-448.
50. Halling SM, Peterson-Burch BD, Bricker BJ, Zuerner RL, Qing Z, Li LL, Kapur FV, Alt DP, Olsen SC. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. Journal of Bacteriology, 2005; 187:2715-2726.